Overview

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare virus response to GW433908/ritonavir (RTV) to viral response to nelfinavir (NFV) when used with abacavir (ABC)/lamivudine (3TC) in patients that have not taken antiretroviral (ART) drugs.

Phase:

Phase 3

Details

Lead Sponsor:

Glaxo Wellcome

Treatments:

Abacavir
Dideoxynucleosides
Fosamprenavir
Lamivudine
Nelfinavir
Ritonavir